WebFeb 7, 2024 · DiscGenics, a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, is expanding their operations in Salt Lake City. The Company has been located at the University of Utah’s Research Park since 2012. Their … WebSep 26, 2024 · DiscGenics. DiscGenics is a company founded in 2007. DiscGenics is a clinical-stage biopharmaceutical company that focuses on developing regenerative cell-based therapies that relief pain and restore …

DiscGenics LinkedIn

WebJan 4, 2024 · DiscGenics, Inc., a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with ... WebDiscGenics’ first product candidate, IDCT, is a homologous, allogeneic, injectable cell therapy for the treatment of patients with mild to moderate degenerative disc disease. … gregory martin facebook

DiscGenics Raises $50 Million in Series C Funding - PR Newswire

WebDiscogenic pain is pain originating from a damaged vertebral disc, particularly due to degenerative disc disease. However, not all degenerated discs cause pain. Disc … WebMay 26, 2024 · Case Summary. On May 23, 2024, Lara Silverman and Jeffrey Poole (“Plaintiffs”), represented by Lauren I. Scholnick of Strindberg Scholnick Birch Hallam Harstad Thorne, filed a civil rights lawsuit against DiscGenics, Inc. (“Defendant”), seeking damages with attorneys’ fees and costs, for Defendant’s alleged gender discrimination … WebNov 18, 2024 · DiscGenics will, first and foremost, see if their cells are safe and reduce pain. As we’ve discussed in prior blogs, a placebo-effect may have provided pain improvement in other, less well designed, studies … fibre optic backbone